08 December 2006
Memory Response in Allografting and Bacterial Infections in Lymphoid and Non-Lymphoid Tissues
Marta Cakala, Waldemar L OlszewskiAnn Transplant 2006; 11(4): 38-44 :: ID: 497043
Abstract
Allografting with immunosuppression is accompanied by chronic rejection and continuing response of the host to infections. Upon first encounter with allogeneic and bacterial antigens the naive T and B cells react within days. Simultaneously cohorts of memory cells are created characterized by rapid response to the second antigenic stimulus. A number of unanswered questions remains as to whether where are the memory cells located, do they persist in the region of the first encounter with antigens or are they mobilized from the bone marrow and spleen, do they react differently to allogeneic and bacterial antigens, are they sensitive to the immunosuppressive drugs? This review cumulates recent data on the subject. Scanty information points to the necessity of more intensive studies on memory cells to allogeneic, bacterial and self-antigens after transplantation in the environment saturated with immunosuppressive drugs.
Keywords: Allograft, Bacteria, Infection, Rejection, Memory Cells
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






